Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07466511
NA

Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis

Sponsor: Second Affiliated Hospital of Wenzhou Medical University

View on ClinicalTrials.gov

Summary

Researchers hypothesized that Bifidobacterium breve Supplement could reduce the progression rate of idiopathic scoliosis in children and potentially prevent the occurrence of new cases of scoliosis.

Official title: Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis: A Prospective, Single-Blind, Randomized Controlled Trial

Key Details

Gender

All

Age Range

6 Years - 15 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2027-01-01

Completion Date

2030-12-31

Last Updated

2026-03-12

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium breve

Oral Bifidobacterium breve supplementation, 4.5 × 10\^6 CFU daily for 6 months

BEHAVIORAL

Lifestyle Education

A standardized education session delivered at baseline on diet optimization, appropriate exercise, and avoidance of unnecessary antibiotic use.

Locations (1)

The Second Affiliated Hospital of Wenzhou Medical University, Zhejiang, Zhejiang 325000

Wenzhou, Zhejiang, China